--- title: "MetLife, Inc. (NYSE:MET) Given Consensus Rating of \"Moderate Buy\" by Analysts" description: "MetLife, Inc. (NYSE:MET) has received a consensus rating of \"Moderate Buy\" from thirteen analysts. One analyst rated it as hold, while twelve rated it as buy. The average 1-year target price is $54. R" type: "news" locale: "en" url: "https://longbridge.com/en/news/215149460.md" published_at: "2024-09-25T06:51:32.000Z" --- # MetLife, Inc. (NYSE:MET) Given Consensus Rating of "Moderate Buy" by Analysts > MetLife, Inc. (NYSE:MET) has received a consensus rating of "Moderate Buy" from thirteen analysts. One analyst rated it as hold, while twelve rated it as buy. The average 1-year target price is $54. Recent reports show mixed price target adjustments from various firms. Institutional investors hold 89.81% of the stock. MetLife's stock opened at $45.45, with a market cap of $54.21 billion. The company reported earnings of $1.28 per share, exceeding estimates, and announced a quarterly dividend of $0.545, yielding 2.71%. MetLife, Inc. (NYSE:MET - Get Free Report) has received a consensus rating of "Moderate Buy" from the thirteen ratings firms that are currently covering the company, Marketbeat reports. One equities research analyst has rated the stock with a hold rating and twelve have given a buy rating to the company. The average 1-year target price among brokerages that have covered the stock in the last year is $84.54. - 2 Insurance Stocks Poised For Major Breakouts MET has been the topic of several research reports. Morgan Stanley dropped their price objective on shares of MetLife from $86.00 to $85.00 and set an "overweight" rating on the stock in a report on Monday, August 19th. Jefferies Financial Group upped their price target on MetLife from $83.00 to $86.00 and gave the stock a "buy" rating in a research note on Thursday, July 18th. Bank of America reduced their price objective on MetLife from $99.00 to $96.00 and set a "buy" rating for the company in a research note on Thursday, August 1st. StockNews.com downgraded MetLife from a "buy" rating to a "hold" rating in a report on Tuesday, September 10th. Finally, Citigroup increased their target price on MetLife from $83.00 to $89.00 and gave the stock a "buy" rating in a report on Tuesday, July 23rd. **View Our Latest Report on MetLife** ## Institutional Trading of MetLife - MarketBeat Week in Review – 8/21 - 8/25 A number of institutional investors and hedge funds have recently modified their holdings of MET. Gilbert & Cook Inc. increased its position in shares of MetLife by 4.6% during the 4th quarter. Gilbert & Cook Inc. now owns 13,872 shares of the financial services provider's stock valued at $917,000 after purchasing an additional 605 shares during the last quarter. Gryphon Financial Partners LLC purchased a new stake in MetLife during the fourth quarter worth about $201,000. Cambridge Investment Research Advisors Inc. raised its position in MetLife by 7.8% in the fourth quarter. Cambridge Investment Research Advisors Inc. now owns 78,499 shares of the financial services provider's stock worth $5,191,000 after acquiring an additional 5,707 shares during the period. US Bancorp DE boosted its stake in MetLife by 1.3% in the fourth quarter. US Bancorp DE now owns 106,391 shares of the financial services provider's stock valued at $7,036,000 after acquiring an additional 1,340 shares during the last quarter. Finally, Nomura Asset Management Co. Ltd. grew its position in shares of MetLife by 0.4% during the 4th quarter. Nomura Asset Management Co. Ltd. now owns 185,735 shares of the financial services provider's stock valued at $12,283,000 after acquiring an additional 816 shares during the period. 89.81% of the stock is owned by hedge funds and other institutional investors. ## MetLife Stock Down 1.2 % Shares of MetLife stock opened at $80.45 on Wednesday. The stock's 50-day moving average is $74.90 and its 200 day moving average is $72.78. MetLife has a one year low of $57.91 and a one year high of $81.85. The firm has a market cap of $57.21 billion, a price-to-earnings ratio of 27.65, a PEG ratio of 0.61 and a beta of 1.04. The company has a debt-to-equity ratio of 0.56, a current ratio of 0.16 and a quick ratio of 0.16. - This Insurance Giant Looks Ready For A Breakout MetLife (NYSE:MET - Get Free Report) last released its quarterly earnings data on Wednesday, July 31st. The financial services provider reported $2.28 earnings per share for the quarter, beating the consensus estimate of $2.13 by $0.15. The company had revenue of $17.82 billion during the quarter, compared to analyst estimates of $18.57 billion. MetLife had a net margin of 4.23% and a return on equity of 21.41%. MetLife's revenue for the quarter was up 7.2% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.94 EPS. Equities research analysts anticipate that MetLife will post 8.67 EPS for the current year. ## MetLife Announces Dividend The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 10th. Stockholders of record on Tuesday, August 6th were paid a $0.545 dividend. The ex-dividend date of this dividend was Tuesday, August 6th. This represents a $2.18 dividend on an annualized basis and a dividend yield of 2.71%. MetLife's payout ratio is presently 74.91%. ## About MetLife (Get Free Report MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. ## See Also - Five stocks we like better than MetLife - Where to Find Earnings Call Transcripts - Biohaven Stock Soars on Drug Trial Results: Time to Jump In? - 3 Healthcare Dividend Stocks to Buy - Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch - What is Insider Trading? What You Can Learn from Insider Trading - Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges *This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.* → CNBC’s ‘Prophet’ issues urgent Fed warning (From Stansberry Research) (Ad)## Should you invest $1,000 in MetLife right now? Before you consider MetLife, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list. While MetLife currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys. View The Five Stocks Here ### Related Stocks - [MET.US - MetLife](https://longbridge.com/en/quote/MET.US.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | 在近期股價上漲之後，評估大都會人壽（MET）的估值 | 大都會人壽 (MET) 的股票在過去一個月上漲了 4.8%，在過去三個月上漲了 5.5%，儘管年初至今下降了 1.4%，仍然吸引了投資者的關注。目前交易價格為 79.22 美元，相較於分析師的平均目標價 91.73 美元和公允價值估計 92 | [Link](https://longbridge.com/en/news/276323778.md) | | 大都會人壽的技能在行動：助力非營利組織蓬勃發展 | 大都會人壽通過其 “影響力技能” 項目賦能非營利組織，員工志願者運用他們的專業知識幫助像法律服務志願者這樣的組織應對關鍵挑戰。該倡議突顯了大都會人壽對社區支持的承諾以及志願服務的積極影響。欲瞭解更多信息，請訪問 3blmedia.com | [Link](https://longbridge.com/en/news/276371249.md) | | 當 “飛機發動機” 成為 “數據中心供電” 標的 | 隨着 AI 數據中心對電力需求的指數級增長，傳統電網擴容的滯後已成為行業公敵。這一背景下，FTAI Aviation、ProEnergy 等公司正加速將航空動力資產 “降維” 引入電力市場。 | [Link](https://longbridge.com/en/news/276216835.md) | | 億萬富翁 Dan Loeb 目前鍾愛的 1 只核能股票 | 1 只億萬富翁丹·洛布現在鍾愛的核能股票 | [Link](https://longbridge.com/en/news/276370391.md) | | UNUM 集團董事 Timothy F. Keaney 出售了普通股 | Unum Group 董事 Timothy F. Keaney 已出售 4,500 股 Unum Group 普通股。完整的文件可通過提供的鏈接獲取。此新聞簡報由 Public Technologies 生成，僅供參考，不應被視為財務、投資 | [Link](https://longbridge.com/en/news/276492208.md) | --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.